Intuitive Investments Group plc
Light Science Technologies Holdings plc's Intention To Float Announcement
Intuitive Investments Group plc (AIM: IIG) ("IIG" or the "Company"), a closed-end investment company focussed on the life sciences sector, notes the Schedule One announcement, released today on behalf of Light Science Technologies Holdings plc ("LSTH"), in relation to the proposed admission of LSTH's ordinary shares to trading on AIM ("Admission").
As announced on 11 January 2021, IIG's investment in LSTH consists of £1 million of convertible loan notes, which have a 7.25% coupon and will convert automatically at a 20% discount to LSTH's ordinary share price at Admission. LSTH was IIG's first investment from its pipeline of opportunities, following its successful IPO and Admission to AIM in December 2020.
For further information, please contact:
| Intuitive Investments Group plc | |
| David Evans, Executive Chairman Robert Naylor, CEO | Via Walbrook PR |
|
|
|
| Strand Hanson Limited - Nominated Adviser | +44 (0) 20 7409 3494 |
| James Dance / James Bellman
|
|
| Turner Pope Investments (TPI) Ltd - Broker | +44 (0) 20 3657 0050 |
| Andrew Thacker / James Pope |
|
|
|
|
| Walbrook PR Limited - Media & Investor Relations | +44 (0)20 7933 8780 or intuitive@walbrookpr.com |
| Sam Allen / Paul McManus | +44 (0)7502 558 258 / +44 (0) 7980 541 893 |
About Intuitive Investments Group plc
The Company is a recently established investing company, seeking to provide investors with exposure to a portfolio concentrating on fast growing and/or high potential Life Sciences businesses operating predominantly in the UK, continental Europe and the US, utilising the Board's experience and in particular that of the Chairman, David Evans, to seek to generate capital growth over the long term for shareholders.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
